According to medical statistics, more than half of all women on the planet after 35 years are at risk of developing heart disease or already suffer from such pathologies. To treat heart diseases, cardiologists often prescribe Riboxin - indications for the use of this medication include a wide range of myocardial damage and other ailments associated with oxygen starvation of tissues and internal organs.
Indications for use Riboxin intravenously
The liquid form of the drug is available in ampoules of 20 ml. Of these, 1 ml accounted for the active ingredient - inosine.
The main indications for the use of Riboxin injections are due to the ability of the substance under consideration to stimulate metabolic processes in the body. Inosine produces the following effects:
- antiarrhythmic;
- antihypoxic;
- improvement of blood circulation in the coronary arteries;
- increased energy balance of the myocardium;
- activation of glucose metabolism;
- prevention of intraoperative kidney ischemia;
- normalization of tissue respiration processes;
- stimulation of nucleotide synthesis;
- an increase in the contractile force of the heart and stroke volume;
- intensification of tissue regeneration;
- relaxation of the myocardium in diastole.
Due to such a large number of positive effects, indications for the use of Riboxin in ampoules include the following pathologies:
- cardiac ischemia;
- transfer of myocardial infarction ;
- myocardial dystrophy on the background of infectious diseases;
- disorders of the heart rhythm, including those that developed after the application of glycosides;
- cirrhosis of the liver;
- hepatitis of various origin;
- fatty liver dystrophy.
In addition, drug injections are used as a drug of pharmacological protection during surgical interventions on an isolated kidney, when it is required to be temporarily switched off from the circulation.
Indications for use of Riboxin capsules according to the instructions
Another form of release of the described drug is prescribed in the period of non-acute conditions, for planned treatment outside the hospital clinic.
Riboxin in the form of capsules is used for such diseases and conditions:
- acquired, congenital heart defects;
- glycoside intoxication;
- cardiac ischemia;
- dystrophic changes in the tissues of the myocardium after endocrine, infectious diseases, as well as excessive physical exertion;
- fatty degeneration of the liver;
- therapy after a previous myocardial infarction;
- heart rhythm disturbances;
- myocardial dystrophy;
- prevention of the development of leukopenia during radioactive irradiation;
- myocarditis;
- cirrhosis of the liver;
- hepatitis, including alcohol and drug type.
Indications for the use of tablets Riboxin
Also, the preparation is presented in tablet form, the dosage of the active ingredient in this case being the same as the concentration of inosine in the capsules and is 200 mg. There are many varieties of Riboxin tablets - LekT, Darnitsa, Ferein, UVI, Vero, PNITIA and others. They are no different, the names are determined by the company that produces the medication.
Tablets are recommended in the following situations:
- complex treatment of ischemic heart disease;
- the recovery period after myocardial infarction;
- disorders of the heart rhythm against the background of glycosides;
- urocoppororphyria;
- cirrhosis, fatty degeneration of the liver ;
- hepatitis.
It is worth noting that the indications for the use of Riboxin LekT do not include conditions in arrhythmia and other cardiac arrhythmias if they are not caused by glycosidic intoxication.